Literature DB >> 22994361

Cerebral astroblastoma in an adult: an immunohistochemical, ultrastructural and genetic study.

Yong-Juan Fu1, Yoshinori Taniguchi, Shigekazu Takeuchi, Atsushi Shiga, Kouichirou Okamoto, Junko Hirato, Sumihito Nobusawa, Yoichi Nakazato, Akiyoshi Kakita, Hitoshi Takahashi.   

Abstract

Astroblastoma is a rare glial tumor of unknown origin, usually affecting the cerebral hemispheres of children and young adults. Here we report an unusual cerebral tumor in a 60-year-old woman. On MRI, the tumor appeared as a well circumscribed lesion in the left frontal lobe. Histopathologically, it was composed of rounded eosinophilic cells, and was divisible into two areas. One area was characterized by a collection of GFAP-positive cells around sclerotic blood vessels (astroblastic pseudorosettes and perivascular hyalinization), and had a Ki-67 labeling index of 2.8%. However, the other area was highly cellular, showing many GFAP-negative cells often with a rhabdoid appearance, mitoses and a Ki-67 index of 15.7%. Thus, a final diagnosis of malignant astroblastoma was made. In both areas of the tumor, nearly all the cells were positive for epithelial membrane antigen, and many were positive for oligodendrocyte transcription factor 2 (Olig2). Focal expression of cytokeratin was also evident. With regard to genetic markers, the tumor cells were positive for INI1 and negative for mutant IDH1. The p53 labeling index was <1%. Ultrastructurally, the presence of intra- and intercellular lumina with microvilli was a feature. DNA examination of IDH1/2 and TP53 showed no mutations. In conclusion, although ependymal features were evident ultrastructurally in the present tumor, the immunohistochemical expression pattern of Olig2 was that of diffuse astrocytoma. On the other hand, the absence of mutations in both IDH1/2 and TP53 suggested that the present tumor was not a purely astrocytic neoplasm. Further studies, including molecular and genetic analyses, will provide insight into the histogenesis of astroblastoma.
© 2012 Japanese Society of Neuropathology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22994361     DOI: 10.1111/j.1440-1789.2012.01351.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   2.076


  6 in total

Review 1.  Neuroradiologic characteristics of astroblastoma and systematic review of the literature: 2 new cases and 125 cases reported in 59 publications.

Authors:  Danielle A Cunningham; Lisa H Lowe; Lei Shao; Natasha R Acosta
Journal:  Pediatr Radiol       Date:  2016-04-05

2.  Astroblastoma: beside being a tumor entity, an occasional phenotype of astrocytic gliomas?

Authors:  Marta Mellai; Angela Piazzi; Cristina Casalone; Silvia Grifoni; Antonio Melcarne; Laura Annovazzi; Paola Cassoni; Tetyana Denysenko; Maria Consuelo Valentini; Angelina Cistaro; Davide Schiffer
Journal:  Onco Targets Ther       Date:  2015-02-19       Impact factor: 4.147

3.  A case of astroblastoma: Radiological and histopathological characteristics and a review of current treatment options.

Authors:  Derek C Samples; James Henry; Fang Frank Yu; Carlos Bazan; Izabela Tarasiewicz
Journal:  Surg Neurol Int       Date:  2016-12-12

4.  Astroblastoma in a Young Female Patient: A Case Report and Literature Review of Clinicopathological, Radiological and Prognostic Characteristics and Current Treatment Strategies.

Authors:  Muhammad Sadiq; Iftikhar Ahmad; Jamila Shuja; Zubair Ahmad; Riyasat Ahmed; Khushnaseeb Ahmad
Journal:  Brain Tumor Res Treat       Date:  2017-10-31

Review 5.  Astroblastoma - a rare and challenging tumor: a case report and review of the literature.

Authors:  Nawal Hammas; Nadia Senhaji; My Youssef Alaoui Lamrani; Sanae Bennis; Elfaiz Mohamed Chaoui; Hind El Fatemi; Laila Chbani
Journal:  J Med Case Rep       Date:  2018-04-21

6.  The ten-year evolutionary trajectory of a highly recurrent paediatric high grade neuroepithelial tumour with MN1:BEND2 fusion.

Authors:  Anna Burford; Alan Mackay; Sergey Popov; Maria Vinci; Diana Carvalho; Matthew Clarke; Elisa Izquierdo; Aimee Avery; Thomas S Jacques; Wendy J Ingram; Andrew S Moore; Kieran Frawley; Timothy E Hassall; Thomas Robertson; Chris Jones
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.